Content about Antivirals

April 20, 2012
Two strategies for managing anemia in hepatitis C patients work equally well, Merck says

Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.

September 6, 2011
Armada Health Care, Hemispherx sign sales, distribution agreement for Alferon N Injection

Hemispherx Biopharma and Armada Health Care have entered a sales and marketing agreement for a drug designed to treat genital warts.

July 25, 2011
New drugs to alter HCV treatment, outcomes

A phrase like “silent killer” sounds creepy enough on its own, but it’s an often-used one for a virus that, according to the Centers for Disease Control and Prevention, infects 1.3% to 1.9% of people in the United States.


July 19, 2011
Graceway receives regulatory approval for Zyclara

The Food and Drug Administration has approved a drug made by Graceway Pharmaceuticals for actinic keratoses, Graceway said.

June 30, 2011
Valeant buys rights for Elidel, Xerese

Canadian drug maker Valeant Pharmaceuticals International will acquire rights to topical drugs for eczema and cold sores from Swedish drug maker Meda.

June 16, 2011
Axium adds new drugs to HepVisions therapy management program

Specialty pharmacy provider Axium Healthcare Pharmacy has introduced two recently approved hepatitis C drugs to its HepVisions therapy management program, the company said Thursday.

May 23, 2011
FDA approves Incivek as hepatitis C treatment

The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.

May 23, 2011
Patients, gov’t benefit from generic SSRI, SNRI adherence

The $290 billion that poor medication adherence costs the U.S. economy every year cuts across every imaginable disease state, but one in which it can be particularly problematic is mental health.


May 16, 2011
Victrelis approved by FDA as chronic hepatitis C treatment

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

April 20, 2011
Mylan launches generic Famvir

Mylan has launched a generic drug for treating herpes, the company said Wednesday.

April 18, 2011
Taro receives FDA approval for generic Aldara

The Food and Drug Administration has approved a topical treatment for skin conditions made by Israeli generic drug maker Taro Pharmaceutical Industries.

April 12, 2011
Medco: Antidepressant use may boost adherence among hepatitis C patients

Medication adherence among hepatitis C patients may improve when patients take antidepressants, according to a new analysis by pharmacy benefit manager Medco Health Solutions presented Monday at the International Conference on Viral Hepatitis.

March 24, 2011
Actavis' generic Valtrex OKed by FDA

The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

March 24, 2011
Sandoz gets OK for authorized generic of Famvir

Sandoz has introduced an authorized generic version of a herpes treatment made by parent company Novartis, the company said Thursday.

March 22, 2011
Watson introduces generic Famvir

A subsidiary of Watson Pharmaceuticals has launched a treatment for herpes infections, the company said Monday.

March 1, 2011
Cold sore treatment Xerese enters market

Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

February 3, 2011
Valeant receives U.S., Canadian rights for Zovirax

Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

November 4, 2010
Merck releases results from phase-3 studies of hepatitis C drug

An investigative treatment for hepatitis C got strong results in patients who had failed previous...

October 31, 2010
Valeant, Kadmon to partner on antiviral drug development

Drug makers Valeant Pharmaceuticals International and Kadmon Pharmaceuticals will collaborate to develop antiviral drugs for...

October 17, 2010
FDA OKs expanded use of Baraclude

The Food and Drug Administration has approved an additional use for a hepatitis drug....

September 27, 2010
Waiting period for Bristol-ZymoGenetics deal expires

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 14, 2010
FDA issues new dosing guide for children using Valcyte

The Food and Drug Administration has approved new dosing recommendations for children and adolescents using...

September 8, 2010
Perrigo gets approval for generic Aldara

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

September 7, 2010
Bristol-Myers Squibb to acquire ZymoGenetics

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 30, 2010
Sigmapharm files ANDA for generic Hepsera

A generic drug maker has filed an abbreviated new drug application for its version of...

© 2012 Drug Store News. All Rights Reserved.